A genetically modified version of the coldsore virus could be used to treat skin cancer within a year.

Scientists injected it into tumours and found it released substances to help fight the disease.

The study of more than 400 people with inoperable malignant melanoma found the therapy could lengthen survival rates in some patients by years.

Dr Emma Smith from Cancer Research UK is urging caution, though.